Downs v. River City Group LLC et al
Filing
355
ORDER granting in part and denying in part 281 motion in limine to exclude other litigation, complaints, investigations, settlements, or other unrelated matters; denying 299 motion in limine to exclude Beverly Paschal's and Dr. Richard Harris' testimony; denying 302 motion in limine to exclude expert Thomas Tarter. Signed by Judge Larry R. Hicks on 2/13/2015. (Copies have been distributed pursuant to the NEF - KR)
1
2
3
4
5
6
UNITED STATES DISTRICT COURT
7
DISTRICT OF NEVADA
8
***
)
)
)
)
)
)
)
)
)
)
)
9
LINDA DOWNS,
10
Plaintiff,
11
v.
12
RIVER CITY GROUP, LLC; et al.,
13
Defendants.
3:11-CV-00885-LRH-WGC
ORDER
14
15
Before the court are defendant Wells Fargo Bank, N.A.’s (“Wells Fargo”) three remaining
16
pretrial motions in limine: (1) motion in limine to exclude other litigation, complaints,
17
investigations, settlements, or other unrelated matters (Doc. #2811); (2) motion in limine to exclude
18
Beverly Paschal’s and Dr. Richard Harris’ testimony (Doc. #299); and (3) motion in limine to
19
exclude expert Thomas Tarter (Doc. #302). Plaintiff Linda Downs (“Downs”) filed oppositions to
20
each of Wells Fargo’s motions (Doc. ##310, 346, 345 respectively) to which Wells Fargo replied
21
(Doc. ##321, 352, 353).
22
I.
23
Facts and Procedural History
In July, 2005, Downs, along with her husband Ronald, purchased real property through a
24
mortgage note and deed of trust. In early December 2009, Downs and her husband purchased a
25
mortgage payment protection insurance policy advertised by defendant Wells Fargo and
26
1
Refers to the court’s docket number.
1
underwritten by defendant Minnesota Life Insurance Company (“Minnesota Life”). The policy
2
provided for twelve (12) monthly payments of $2,398.23 - the amount of the Downs’ monthly
3
mortgage payment - to Wells Fargo in the event of Ronald’s death.
4
On May 31, 2010, Ronald passed away. On June 10, 2010, Downs contacted both Wells
5
Fargo and Minnesota Life, notified them of Ronald’s passing, and requested disbursement of the
6
payments pursuant to the mortgage insurance policy. On August 18, 2010, Minnesota Life
7
approved Downs’ claim for payment, and sent Wells Fargo a check for $9,572.92 - the amount
8
owed for the mortgage payments from May 2010, through August 2010. Thereafter, Minnesota
9
Life made payments in accord with the payment schedule as prescribed under the policy. However,
10
prior to the disbursement of funds in August 2010, Wells Fargo initiated non-judicial foreclosure
11
proceedings against the underlying property.
12
Subsequently, Downs filed a complaint alleging ten causes of action against all defendants:
13
(1) intentional infliction of emotional distress; (2) negligent infliction of emotional distress;
14
(3) breach of contract; (4) breach of the implied covenants of good faith and fair dealing; (5) unfair
15
claims practices; (6) conspiracy to defraud; (7) negligence; (8) invasion of privacy; (9) unjust
16
enrichment; and (10) quiet title. Doc. #1, Ex. A. After a series of motions to dismiss and motions
17
for summary judgment, the only remaining defendant is defendant Wells Fargo.
18
On January 12, 2015, Wells Fargo filed the present motions in limine to address various
19
evidentiary issues related to some of Downs’ anticipated exhibits and witnesses. The court shall
20
address each motion below.
21
II.
22
Legal Standard
A motion in limine is used to preclude prejudicial or objectionable evidence before it is
23
presented to the jury. Stephanie Hoit Lee & David N. Finley, Federal Motions in Limine § 1:1
24
(2012). The decision on a motion in limine is consigned to the district court’s
25
discretion—including the decision of whether to rule before trial at all. See Hawthorne Partners v.
26
AT&T Techs., Inc., 831 F. Supp. 1398, 1400 (N.D. Ill. 1993) (noting that a court may wait to
2
1
resolve the evidentiary issues at trial, where the evidence can be viewed in its “proper context”).
2
Motions in limine should not be used to resolve factual disputes or to weigh evidence, and
3
evidence should not be excluded prior to trial unless “the evidence [is] inadmissible on all potential
4
grounds.” See, e.g., Ind. Ins. Co. v. Gen. Elec. Co., 326 F. Supp. 2d 844, 846 (N.D. Ohio 2004).
5
Even then, rulings on these motions are not binding on the trial judge, and they may be changed in
6
response to developments at trial. See Luce v. United States, 469 U.S. 38, 41 (1984).
7
Generally, all relevant evidence is admissible. FED. R. EVID. 402. Evidence is relevant if it
8
has “any tendency to make the existence of any fact that is of consequence to the determination of
9
the action more probable or less probable than it would be without the evidence.” FED. R. EVID.
10
401. The determination of whether evidence is relevant to an action or issue is expansive and
11
inclusive. See Sprint/United Mgmt. Co. v. Mendelsohn, 552 U.S. 379, 384-87 (2008). However,
12
the court may exclude otherwise relevant evidence “if its probative value is substantially
13
outweighed by the danger of unfair prejudice.” FED. R. EVID. 403. Further, evidence may be
14
excluded when there is a significant danger that the jury might base its decision on emotion or
15
when non-party events would distract reasonable jurors from the real issues in a case. See Tennison
16
v. Circus Circus Enterprises, Inc., 244 F.3d 684, 690 (9th Cir. 2001); United States v. Layton, 767
17
F.2d 549, 556 (9th Cir. 1985).
18
III.
19
Discussion
A. Motion in Limine to Exclude Other Litigation, Complaints, Investigations,
Settlements, or Other Unrelated Matters (Doc. #281)
20
21
In her proposed exhibits and witness lists, Downs seeks to offer evidence of other litigation
22
involving Wells Fargo, in particular evidence of Dollens v. Wells Fargo, as well as evidence
23
involving a settlement between Wells Fargo and the Comptroller of the Currency. In the present
24
motion, Wells Fargo seeks to exclude all evidence, testimony, and documentation about both
25
issues. See Doc. #281. The court shall address each issue separately below.
26
///
3
1
2
1. Dollens Case
Wells Fargo seeks exclusion of all evidence relating to the Dollens v. Wells Fargo case, a
3
state court case from New Mexico, which involves a similar factual pattern involving Wells
4
Fargo’s attempts to foreclose on property before the payment of mortgage insurance. In her exhibit
5
list, Downs has listed as exhibits the second amended complaint in Dollens, Wells Fargo’s answer
6
to the second amended complaint, the court’s final findings of fact and conclusions of law, and the
7
final judgment against Wells Fargo. Additionally, Downs has identified two witnesses that would
8
testify about the Dollens case: Beverly Decaro and Andrew Pizor.
9
The court has reviewed Wells Fargo’s motion and finds that evidence relating to the
10
Dollens case is both relevant and admissible in this action under the Federal Rules of Evidence. In
11
particular, the court finds that evidence about the Dollens case is relevant to establishing that Wells
12
Fargo’s business practices is to routinely foreclose on the mortgages it services without proper
13
internal controls and regardless of insurance coverage. Further, the evidence is admissible under
14
Rule 404(b) as evidence of Wells Fargo’s other wrongs or acts to show proof of Wells Fargo’s
15
knowledge of problems in its loan servicing, that it was not complying with federal regulations,
16
and that it was improperly crediting payments to fees rather than principal and interest payments.
17
Further, the evidence is also admissible under Rule 404(b) to show that Wells Fargo’s treatment of
18
Downs was not a mistake but was part of a larger problem at Wells Fargo during the relevant time
19
period. This evidence can be presented from the two identified witnesses who Downs seeks to have
20
testify at trial and who were present at and testified in the Dollens matter.
21
However, as to the actual physical exhibits the court makes the following findings. The
22
court finds that the judgment, findings of fact and conclusions of law, second amended complaint,
23
and answer to the second amended complaint are not admissible. The second amended complaint
24
and answer to the second amended complaint are not relevant to any of Downs’ causes of action.
25
The second amended complaint in Dollens alleges different causes of action, and is a document
26
containing only allegations against Wells Fargo. It is not proof of any of Wells Fargo’s conduct.
4
1
Similarly, Wells Fargo’s answer is not relevant to the present action.
As to the Dollens’ judgment and final findings, the court finds that these documents are
2
3
inadmissible under Rule 403. See FED. R. EVID. 403 (stating that the court may exclude otherwise
4
relevant evidence “if its probative value is substantially outweighed by the danger of unfair
5
prejudice.”). Here, any probative value of the judgment is substantially outweighed by the
6
prejudicial effect the document would have. Presenting the jury with a judgment against Wells
7
Fargo for more than 2.7 million dollars when the document does not address or identify what the
8
judgment was for, would unfairly prejudice Wells Fargo as the jury may find that because another
9
court entered an award against Wells Fargo, they should too. Thus, there is a significant danger that
10
the jury might base its decision on emotion or other non-issues if this evidence was admitted. See
11
Tennison v. Circus Circus Enterprises, Inc., 244 F.3d 684, 690 (9th Cir. 2001); United States v.
12
Layton, 767 F.2d 549, 556 (9th Cir. 1985).
13
As to the final findings of fact and conclusion of law, the court notes that this evidence also
14
suffers the same prejudicial problem as the judgment as it makes specific findings against Wells
15
Fargo for certain monetary amounts. Further, the evidence is even more prejudicial than the
16
judgment because it is accompanied by factual findings by a judge based on evidence that will not
17
be presented to the jury and dealing with causes of action not raised in this case, like breach of
18
contract and violation of the Unfair Debt Collection Practices Act. Therefore, the court shall grant
19
in-part and deny in-part Wells Fargo’s motion and exclude only the specific documents related to
20
the Dollens case identified by Downs.
21
2. OCC Consent Decree
22
In her pretrial disclosures, Downs identified a consent decree from the Office of the
23
Comptroller of Currency (“OCC”) in which Wells Fargo agreed to settle various banking
24
regulation disputes, enact certain remedial measures to prevent future violations of certain banking
25
regulations, and make monetary payments to several thousand affected Wells Fargo customers.
26
///
5
1
As addressed above, evidence that goes to Wells Fargo’s knowledge of its practices during
2
the relevant time period and the lack of mistake when servicing Downs’ mortgage is relevant
3
evidence that Downs can seek to introduce at trial. However, as to the actual consent decree
4
document itself, the court finds that it is inadmissible under Rule 403 because it is unfairly
5
prejudicial to Wells Fargo and highly confusing to the jury given the fact that it is a settlement for
6
violations of banking regulations not at issue in this case and does not admit liability by Wells
7
Fargo. As such, the court shall exclude the exhibit itself, but not testimony about the consent
8
decree that may be relevant to Downs’ causes of action.
9
B. Motion in Limine to Exclude Beverly Paschal’s and Dr. Richard Harris’
Testimony (Doc. #299)
10
11
Wells Fargo seeks to exclude from trial testimony of Downs’ physician Dr. Richard Harris
12
(“Harris”) and mental health therapist Beverly Paschal (“Paschal”) arguing that the testimony is (1)
13
not helpful to the trier of fact, (2) not based on reliable principles and methods, and (3) not
14
supported by expert reports. Doc. #299.
15
In opposition, Downs argues that the testimony of Harris and Paschal is highly relevant,
16
would help the trier of fact, and is based on reliable principles and methods. Additionally, Downs
17
argues that expert reports are not required for this testimony because Harris and Paschal were not
18
specially retained to testify at trial, and both formed their opinions during their course of treatment
19
of Downs.
20
To prevail on her claim for intentional infliction of emotional distress, Downs must
21
demonstrate that “she has suffered some physical manifestation of emotional distress.” Betsinger v.
22
D.R. Horton, Inc., 232 P.3d 433, 436 (Nev. 2010). Nevada law states that “because an injury is a
23
subjective condition, an expert opinion is required to establish a causal connection between the
24
incident or injury and disability.” Grover C. Dils Med. Ctr. v. Menditto, 112 P.3d 1093, 1100 (Nev.
25
2005) (internal quotation omitted). An expert witness can testify about his or her opinion on a
26
matter if “(a) the expert’s . . . specialized knowledge will help the trier of fact to understand the
6
1
evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data;
2
(c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably
3
applied the principles and methods to the facts of the case.” Fed. R. Evid. 702.
4
The district court must ensure “that an expert’s testimony both rests on a reliable
5
foundation and is relevant to the task at hand.” Daubert v. Merrell Dow Pharm., Inc., 509 U.S.
6
579, 597 (1993). “This entails a preliminary assessment of whether the reasoning or methodology
7
underlying the testimony is scientifically valid and of whether that reasoning or methodology
8
properly can be applied to the facts in issue.” Id. at 592-93.
Although “[m]any factors will bear on the inquiry,” some of the considerations
considered relevant by the Supreme Court to such an assessment include: (a)
whether the theory or technique can and has been tested; (b) whether the theory or
technique has been subjected to peer review and publication; (c) the known or
potential rate of error for the technique; and (d) the theory or technique's general
degree of acceptance in the relevant scientific community.
9
10
11
12
13
Boyd v. City and Cnty. of S.F., 576 F.3d 938, 945 (9th Cir. 2009) (citing Daubert, 509 U.S. at 593-
14
94).
15
In its motion, Wells Fargo argues that Harris and Paschal admit that they do not have a
16
specialized understanding of Downs’ physical problems because they cannot “quantify the impact
17
of Wells Fargo’s conduct—as opposed to Downs’s other stressors or external factors.” Doc. #299
18
at 4. As a result, Wells Fargo argues that their testimony is “purely speculative.” Id. at 5. The court
19
disagrees. Downs has presented evidence that Harris and Paschal are highly experienced in their
20
fields and have treated Downs for nearly twelve years. Doc. #346 at 3. Harris is a physician who
21
specializes in pain management. Id. at 4. Downs argues that his testimony “will be helpful to show
22
that Wells Fargo’s tortious conduct caused Mrs. Downs’ stress and pain, and decreased her
23
functional capacity.” Id. Harris has testified that he concluded based on his treatment of Downs
24
that the foreclosure contributed to her fibromyalgia pain. Id. Paschal is a licensed marriage and
25
family therapist who specializes in traumatic stress and has treated Downs since 2003. Id. Downs
26
argues that her testimony “will assist the trier of fact by showing the harmful effects that Wells
7
1
Fargo’s tortious conduct had on Mrs. Downs, including emotional distress and anxiety, which
2
manifested in a number of physical symptoms.” Id. Paschal has testified that Downs’ anxiety
3
increased dramatically after she received the first foreclosure notice. Id.
4
Wells Fargo further argues that Harris’ testimony regarding fibromyalgia is inadmissible
5
because the scientific community lacks consensus on the cause of fibromyalgia. However, Harris
6
has stated that he intends to testify not about the cause of the disease, but that the foreclosure
7
exacerbated Downs’ fibromyalgia pain. Doc. #346 at 7. Harris is the physician who diagnosed
8
Downs’ fibromyalgia, and has testified to a reasonable degree of medical certainty that the
9
foreclosure exacerbated her fibromyalgia pain. Id. Although Wells Fargo is correct that Harris
10
identifies a number of other factors that contribute to Downs’ fibromyalgia pain, his testimony
11
regarding certain incidents that increased Downs’ pain could certainly be helpful to a jury, and no
12
evidence before the court indicates that Harris’ methods are unreliable. The central question for the
13
court is whether physicians would accept the testimony as “useful and reliable,” but the testimony
14
“need not be conclusive because ‘medical knowledge is often uncertain.’” Primiano v. Cook, 598
15
F.3d 558, 565 (9th Cir. 2010) (quoting United States v. Sandoval-Mendoza, 472 F.3d 645, 655 (9th
16
Cir. 2006)). Furthermore, other courts have permitted expert testimony regarding diagnosis and
17
treatment of fibromyalgia. See, e.g., Prest v. Jermstad, No. 07-cv-1771, 2009 WL 3634114, at *7
18
(S.D. Cal. Oct. 30, 2009) (noting that the witness’s “experience treating patients with fibromyalgia,
19
and his work doing fibromyalgia research qualify him as an expert witness on the diagnosis and
20
treatment of fibromyalgia”). Accordingly, the Court will not exclude Harris’ expert testimony
21
regarding Downs’ fibromyalgia pain at this time.
22
Finally, Wells Fargo argues that the testimony of Harris and Paschal is inadmissible
23
because neither witness produced a written report as required by Federal Rule of Civil Procedure
24
26(a)(2)(B), and their opinions were not formed during the regular course of their treatment of
25
Downs because each witness largely relied on Downs’ own representations regarding the cause of
26
her pain. Doc. #299 at 7-8. The expert report requirement only applies to witnesses who were
8
1
“retained or specially employed to provide expert testimony . . . or whose duties as the party’s
2
employee regularly involve giving expert testimony.” Fed. R. Civ. P. 26(a)(2)(B). The Ninth
3
Circuit holds that “a treating physician is not ‘retained or specially employed to provide expert
4
testimony’—a treating physician is a percipient witness of the treatment he rendered—and
5
therefore he is not subject to the written report requirement.” Goodman v. Staples The Office
6
Superstore, LLC, 644 F.3d 817, 824 (9th Cir. 2011). However, “a treating physician is only exempt
7
from Rule 26(a)(2)(B)’s written report requirement to the extent that his opinions were formed
8
during the course of treatment.” Id. at 826. In Goodman, the court held that although the plaintiff’s
9
doctors were her treating physicians, they were not exempt from the Rule 26(a)(2)(B) written
10
report requirement largely because they “reviewed information provided by Goodman’s attorney
11
that they hadn’t reviewed during the course of treatment.” Id.
12
Here, there is no evidence that Harris or Paschal based their opinions about Downs’ pain on
13
evidence provided by Downs’ attorney, as opposed to their own treatment. Harris stated in his
14
deposition that Downs’ fibromyalgia “has gotten much worse” since the foreclosure proceedings
15
began. Doc. #346, Ex. 1 at 78:23-79:2. This is supported by Harris’ progress notes, which were
16
written in the course of Downs’ treatment. See id., Ex. 2. Paschal has testified that all opinions
17
regarding Downs’ condition were formed during her treatment of Downs. See Doc. #299, Ex. 4 at
18
54:14-16, 56:4-8. Based on the evidence before the Court, Harris and Paschal formed their
19
opinions during the course of their treatment of Downs, and are therefore not required to submit an
20
expert report under Rule 26(a)(2)(B). See Elgas v. Co. Belle Corp., 179 F.R.D. 296, 298 (D. Nev.
21
1998) (“Since a treating physician’s opinion on matters such as ‘causation, future treatment, extent
22
of disability and the like’ are part of the ordinary care of a patient, a treating physician may testify
23
to such opinion without being subject to the extensive reporting requirements of Rule
24
26(a)(2)(B).”).
25
26
Based on the foregoing, the court will not exclude the testimony of Harris and Paschal at
this time. Any objections to the form or substance of Harris and Paschal’s testimony are best
9
1
reserved for trial, and any questions regarding Harris and Paschal’s experience or qualifications as
2
experts are best reserved for cross-examination.
3
C. Motion in Limine to Exclude Downs’ Expert Thomas Tarter (Doc. #302)
4
In its last motion in limine, Wells Fargo seeks to exclude from trial the testimony of
5
Downs’ expert witness Thomas Tarter (“Tarter”) because his “opinions lack proper foundation, are
6
not based on reliable methodology, are irrelevant, and are not helpful to the trier of fact.”
7
Doc. #302 at 1.
8
9
An expert witness can testify about his or her opinion on a matter if “(a) the expert’s . . .
specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in
10
issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of
11
reliable principles and methods; and (d) the expert has reliably applied the principles and methods
12
to the facts of the case.” Fed. R. Evid. 702. The District Court must ensure “that an expert’s
13
testimony both rests on a reliable foundation and is relevant to the task at hand.” Daubert, 509 U.S.
14
at 597. “This entails a preliminary assessment of whether the reasoning or methodology underlying
15
the testimony is scientifically valid and of whether that reasoning or methodology properly can be
16
applied to the facts in issue.” Id. at 592-93.
17
A trial court “is not required to rigidly apply the specific factors relating to expert scientific
18
evidence to cases involving expert specialized knowledge evidence.” Visa Int’l Serv. Ass’n v. JSL
19
Corp., No. 2:01-cv-0294, 2006 WL 3248394, at *2 (D. Nev. Nov. 7, 2006) (citing United States v.
20
Hankey, 203 F.3d 1160, 1168-69 (9th Cir. 2000)). For specialized non-scientific testimony like
21
Tarter’s, the district court therefore exercises its gate-keeping function by analyzing the expert’s
22
reliability, which “depends heavily on the knowledge and experience of the expert, rather than the
23
methodology or theory behind” the testimony. Hankey, 203 F.3d at 1169. To determine whether
24
specialized expert testimony is admissible, the court considers: (1) whether the opinion is based on
25
scientific, technical, or other specialized knowledge; (2) whether the opinion would assist the trier
26
of fact in understanding the evidence or determining a fact in issue; (3) whether the expert has the
10
1
appropriate qualifications to render the opinion; (4) whether the testimony is relevant and reliable;
2
(5) whether the methodology or technique used fits the conclusions; and (6) whether the opinion's
3
probative value is substantially outweighed by the risk of unfair prejudice, confusion of issues or
4
undue consumption of time. Hankey, 203 F.3d at 1168.
5
Wells Fargo contends that Tarter is not qualified to opine regarding the insurance product at
6
issue, noting that Tarter’s report does not identify any past experience as an expert on optional life
7
insurance products. Further, Wells Fargo argues that Tarter’s opinions are not based on reliable
8
methods because his conclusions were based largely on personal opinions rather than objective
9
methodology. Moreover, Wells Fargo argues that Tarter’s legal conclusions constitute improper
10
expert witness testimony. Finally, Wells Fargo argues that Tarter’s expert testimony will not help
11
the jury determine facts at issue. The court disagrees.
12
13
14
15
16
17
18
19
20
Tarter’s relevant experience is provided in detail in his expert report. See Doc. #302, Ex. 1
at 5-7. Specifically, Tarter’s expert report states the following:
I am an expert on consumer mortgage lending industry customs, standards and
practices. I have been directly involved in literally thousands of consumer mortgage
loan transactions and have considerable experience in predatory lending . . . . I have
also been retained in excess of 1,000 matters to review documents, facts and
practices to provide expert services on mortgage loan origination, mortgage banker
and/or broker conduct, consumer credit, credit damages, due diligence and
underwriting, compliance, disclosures, lender liability, loan servicing, mortgage
lending customs, standards and practices, loan servicing, records retention practices
and standards and other banking and lending industry issues. In doing so, I have
testified in deposition and/or trial in excess of 200 times and I have been qualified
by federal, state and bankruptcy courts as an expert on credit, damages, disclosures,
lending industry practices, lender liability, loan origination, loan servicing and other
banking and lending issues.
21
Id. at 5. Tarter is also Managing Director of The Andela Consulting Group, a consulting firm that
22
conducts financial and management consulting, litigation consulting, and expert witness services.
23
Id. Tarter has worked for banks and financial institutions for more than forty years, has been
24
involved in lending disputes, and has conducted audits “pertaining to suspicious circumstances
25
involving consumer credit disputes, dispute resolution, loan commitments, underwriting and due
26
diligence, loan servicing, mortgage broker relationships, bank and financial service industry
11
1
practices.” Id. at 6-7.
Downs states that “Tarter’s testimony is now more limited than that disclosed in his expert
2
3
report.” Doc. #345 at 2. Specifically, Tarter will opine that:
Wells Fargo did not have proper internal controls and processes for: (1) prohibiting
delinquency or foreclosure while an insurance claim was pending; (2) processing and
posting Mrs. Downs’ insurance policy payments; (3) investigating and correcting
errors to resolve payment issues with borrowers; (4) determining whether foreclosure
fees were appropriate in the state where the home is located, including Nevada; and
(5) prohibiting foreclosure notice(s) when dispute resolution was ongoing.
4
5
6
7
8
Id. Downs states that Tarter also intends to testify about Wells Fargo’s oral promises to Downs,
9
regulations related to “lender liability,” Wells Fargo’s insufficient supporting documents for
10
corporate advances, and the propriety of Wells Fargo’s conduct. Id. at 5. On its face, Tarter’s
11
expert witness report indicates that Tarter’s testimony would be helpful for a jury, and that he has
12
the training and experience necessary to be qualified as an expert witness. Furthermore, the
13
evidence and opinions that Tarter intends to share appear relevant and reliable, and the probative
14
value of Tarter’s testimony is not substantially outweighed by the risk of unfair prejudice,
15
confusion of issues, or waste of time.
After reviewing the parties’ submissions, the court denies Wells Fargo’s motion to exclude
16
17
Tarter’s expert testimony. Any objections to the form or substance of Tarter’s testimony are best
18
reserved for trial, and any questions regarding Tarter’s experience or qualifications as an expert are
19
best reserved for cross-examination.
20
21
IT IS THEREFORE ORDERED that defendant’s motion in limine to exclude other
22
litigation, complaints, investigations, settlements, or other unrelated matters (Doc. #281) is
23
GRANTED in-part and DENIED in-part in accordance with this order.
24
///
25
///
26
///
12
1
IT IS FURTHER ORDERED that defendant’s motion in limine to exclude Beverly
2
Paschal’s and Dr. Richard Harris’ testimony (Doc. #299); and motion in limine to exclude expert
3
Thomas Tarter (Doc. #302) are DENIED.
4
IT IS SO ORDERED.
5
DATED this 13th day of February, 2015.
__________________________________
LARRY R. HICKS
UNITED STATES DISTRICT JUDGE
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
13
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?